Piramal Pharma Latest Results: Effective Tax Rate Elevated in FY27, Normalization to 24%-25% Ahead 1 min ago
Piramal Pharma disclosed during its concall that the effective tax rate will remain elevated in FY27, with normalization expected in the 24%-25% range as overseas operations scale up over the coming years. The elevated rate reflects the current developmental stage of the company's international business. No specific quarterly revenue or profit figures were provided in the available update.
Vinati Organics Latest Results: EBITDA Margin Guidance of 26-27% for FY27 1 min ago
Piramal Pharma Latest Results: Effective Tax Rate Elevated in FY27, Normalization to 24%-25% Ahead 1 min ago
Piramal Pharma disclosed during its concall that the effective tax rate will remain elevated in FY27, with normalization expected in the 24%-25% range as overseas operations scale up over the coming years. The elevated rate reflects the current developmental stage of the company's international business. No specific quarterly revenue or profit figures were provided in the available update.
Piramal Pharma Latest Results: May Revise FY27 Performance Guidance in Q2 10 mins ago